Rare diseases
Investigational molecules
Locations
453 conditions with trials, the busiest first
1 389 trials across Europe, recruiting first
Study on Long-Term Safety and Effects of PTC518 for Patients with Huntington's Disease
AustriaStudy on the Safety and Tolerability of Lasmiditan for Treating Migraine in Children Aged 6 to 17
BelgiumStudy Comparing Atogepant and Topiramate for Preventive Treatment in Adults with Migraine
AustriaStudy on the Safety and Effects of MBF-015 for Patients with Huntington's Disease
SpainStudy Comparing Gadoquatrane with Gadoteric Acid, Gadobutrol, and Gadoteridol for MRI in Adults with Brain or Spinal Cord Issues
BulgariaStudy on the Effectiveness and Safety of Satralizumab for Patients with Type 1 Facioscapulohumeral Muscular Dystrophy
FranceStudy on the Safety and Effects of Fenfluramine in Infants Aged 1 to Less Than 2 Years with Dravet Syndrome
BelgiumStudy on ACOU085 to Prevent Hearing Loss in Testicular Cancer Patients Receiving Cisplatin
GermanyStudy on the Effectiveness and Safety of Difelikefalin for Adults with Moderate-to-Severe Itching from Notalgia Paresthetica
GermanyStudy of Patritumab Deruxtecan for Patients with Brain Metastases from Advanced Breast or Lung Cancer and Leptomeningeal Disease from Solid Tumors
AustriaStudy on the Effect of Botulinum Toxin Type A and Sodium Chloride for Patients with Chronic Neuropathic Pain
DenmarkStudy on LSTA1 and Temozolomide for Patients with Newly Diagnosed Glioblastoma Multiforme
EstoniaThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
